Archive for the 'pharmacy benefit managers' Category

Senators back more MTM in Medicare drug plans

By Kevin Schweers

A bipartisan report from the Senate Aging Committee focuses on how to increase utilization of generic drugs to lower costs and specifically suggests expanded eligibility for medication therapy management (MTM) services, such as from community pharmacists. Continue reading ‘Senators back more MTM in Medicare drug plans’

The “Lock-In” Pharmacy Approach to Rx Drug Abuse

By Kevin Schweers

A proposal to restrict certain Medicare beneficiaries to use only a dedicated, “lock-in” pharmacy for their controlled substances is now a part of legislation introduced by two House lawmakers. Continue reading ‘The “Lock-In” Pharmacy Approach to Rx Drug Abuse’

Members of Congress Scrutinize Sky-rocketing Costs of Generic Drugs

By Michael Rule

Last January, NCPA urged Congress to investigate soaring generic drug prices after a member survey found that acquisition costs for some drugs had increased by more than 1,000%, but that reimbursement to pharmacies did not keep up. This call was recently answered by Sen. Bernie Sanders (I-Vt.) and Rep. Elijah E. Cummings (D-Md.) who launched an inquiry.

Continue reading ‘Members of Congress Scrutinize Sky-rocketing Costs of Generic Drugs’

Payers Call for Greater PBM Transparency

By Michael Rule

For years, NCPA has been at the forefront in calling for greater transparency in the operations of pharmacy benefit managers (PBMs), from highlighting difficulties plan sponsors often have in auditing their PBM to noting PBM practices that may increase costs to plans while increasing profits for the PBMs. While the PBMs claim there is already adequate transparency, their policies are drawing increased scrutiny.

Continue reading ‘Payers Call for Greater PBM Transparency’

The Morning After

By Kurt A. Proctor, Ph.D., RPh, NCPA Senior Vice President, Strategic Initiatives

After a great NCPA Annual Meeting in Austin, we weren’t done. On Wednesday, October 22nd we kept the momentum going with a day-long “Networking for High Performance Pharmacies” program for a standing room only crowd of 140 industry leaders. This provocative program afforded like-minded pharmacists not only the opportunity to get to know each other but to engage with public and private payers to hear about their plans for pay-for-performance and quality related network inclusion criteria.

Continue reading ‘The Morning After’

Health Economist Shreds PBMs’ Claim of Large Cost Increase from “Any Willing Pharmacy” Medicare Proposal

By Kevin Schweers

Claims by pharmacy benefit managers (PBMs) that a massive cost increase would result from legislation giving Medicare seniors in medically underserved areas more convenient access to discounted or “preferred” copays are “theoretically baseless,” a noted health care economist and antitrust expert argues in a new analysis.

Continue reading ‘Health Economist Shreds PBMs’ Claim of Large Cost Increase from “Any Willing Pharmacy” Medicare Proposal’

Grassroots Efforts Yield Successes in 2013: Keep it up in 2014

By Michael Rule, Associate Director of Grassroots and Public Affairs

From a grassroots perspective, 2013 should be a year that is long remembered by pharmacists. Due to pharmacist engagement, independent community pharmacists achieved pro-patient, pro-pharmacist successes at both the state and federal level and continued to build relationships with legislators through hosting pharmacy visits. Continue reading ‘Grassroots Efforts Yield Successes in 2013: Keep it up in 2014′


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Search by Categories


Follow

Get every new post delivered to your Inbox.

Join 474 other followers